Medical oncology faculty promotions 2014
July 1, 2014 · Comments Off
Four University of Colorado Cancer Center investigators and Department of Medical Oncology faculty were recently...
Breast Cancer Clinical Trial Results Show Promise
May 1, 2014 · Comments Off
A clinical trial shows that an experimental drug along with standard chemotherapy is a beneficial...
$5.9M Grant Adds Androgen Receptor as a New Driver and Target in Breast Cancer
October 1, 2013 · Comments Off
A major Department of Defense grant to researchers Jennifer Richer, PhD, and Anthony Elias, MD, at the University of Colorado Cancer Center aids development of drugs that target androgen receptors as a driver of breast cancer.
May 31, 2013 · Comments Off
Researchers at University of Colorado Cancer Center are discovering how androgens drive diseases such as breast and bladder cancers.
AACR News: Studies show increasing evidence that androgen drives breast cancer
April 10, 2013 · Comments Off
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Clinical trial hits new target in war on breast cancer
December 3, 2012 · Comments Off
KEY POINTS: In addition to estrogen, progesterone and HER2, androgen drives breast cancer The drug...
Annual retreat shows the CU Cancer Center is greater than the sum of its parts
October 31, 2012 · Comments Off
At the annual CU Cancer Center retreat on October 30, Deputy Director Andrew Thorburn, PhD,...
In this every-second-Thursday “Decoding Cancer” series in Target Cancer, and in honor of National Breast...
Safeway gift brings total breast cancer research support at CU Cancer Center above $1 million
April 22, 2011 · Comments Off
A $350,000 gift from Safeway, Inc. will fund breast cancer research at the University of...
NTRK1: a new oncogene and target in lung cancer
April 22, 2011
Wings of Hope to benefit pancreatic cancer research at CU Cancer Center
September 16, 2014 · No comments
A Teal Saturday: Gynecologic Cancer Symposium at CU
September 15, 2014 · No comments
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
“Sandy is interested in leaving a legacy of innovation to ensure that the University of Colorado has the... fb.me/3APlBMaNV
Great news! fb.me/2rRNa1u1A
A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer... fb.me/3ESuyGbqF
Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs... fb.me/3vrD9ACDf